Adalimumab (Humira)
Sponsors
Northwell Health, Abbott, Hvidovre University Hospital, Tufts Medical Center, Rambam Health Care Campus
Conditions
Ankylosing SpondylitisArthritisArthritis; BehcetCardiovascular DiseaseFocal GlomerulosclerosisHealthyJoint DiseasesPsoriasis
Phase 1
Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)
CompletedNCT00193648
Start: 2005-07-31End: 2007-10-31Updated: 2007-10-22
Comparative Clinical Study of Pharmacokinetics, Tolerance and Safety of BCD-057 and Humira in Healthy Volunteers
CompletedNCT02395055
Start: 2015-06-30End: 2015-10-31Updated: 2021-11-05
Phase 3
An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)
CompletedNCT00478660
Start: 2006-02-28Updated: 2007-10-10
Efficacy of Humira in Behcet Patients With Arthritis
CompletedNCT01497717
Start: 2013-07-31End: 2016-10-31Updated: 2016-10-26
Phase 4
Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
CompletedNCT00696059
Start: 2004-08-31End: 2007-07-31Updated: 2008-06-12
Mechanism of Action Study for Psoriasis
CompletedNCT00932113
Start: 2009-06-30End: 2017-05-01Updated: 2017-08-31
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
CompletedNCT01553058
Start: 2012-07-31End: 2016-10-27Updated: 2018-05-22